Sino Grandness T4B

SGD 0.02 +0.00% +0.00 Updated 16 Nov 2026, 12:20 SGT

Company profile

The business, the people and the ownership behind Sino Grandness.

Business overview

About the company

Sino Grandness is a Shenzhen-headquartered food and beverage group. Its FY2023 annual report describes the manufacture and distribution of Garden Fresh juices and canned fruits and vegetables, with sales in China and export markets in Europe, North America and Asia.

Issuer source ↗ Reviewed 2026-10-16 · Source dated 2025-12-28. PDF p. 3

Listed security

Company & listing

Full Company Name
SINO GRANDNESS FOOD INDUSTRY GROUP LIMITED
Trading Currency
SGD
Website
www.grandnessgroups.com
Listing
Listed on 23 November 2009 on SGX Mainboard
ISIN Code
SG2G19997136

Board & management

Leadership

Four statutory Board directors, four additional senior managers and one annual-report Company Secretary. Wang Xiaowei is Director of Overseas Market, not a fifth Board member. Current annual report names no CFO; AGM/EGM minutes mention an unnamed CFO. Historical CFO Huang Yushan is not presented as the current CFO. Company Secretary resignation and later AGM outcomes are separately dated.

FY2023 audit is a Disclaimer of Opinion, signed by RT LLP on 7 November 2025. Going-concern uncertainty, bond litigation exposure and unrecognised Company financial-guarantee provisions form the basis. Management statements about a true and fair view do not constitute the auditor opinion.

Reporting year is FY2023 ended 31 December 2023; signature and authorisation in November 2025 and SGX release on 28 December 2025 do not create a FY2025 annual report. Later FY2025 management accounts and disposal pro forma calculations are unaudited and are not substituted for annual statements.

FY2021 restatement changes owner result from RMB(36,006) to RMB145,465 thousand, and opening retained profits from RMB821,437 to RMB342,379 thousand. Source FY2022 Note39 discloses the adjustments. Original FY2021 statements and separately dated 1 January 2021 opening positions are retained.

The restated 1 January 2021 opening positions are not relabelled as FY2020 closing statements. No fully restated FY2020 profit or cash-flow series is disclosed in Note39. FY2020 closing statements remain from the FY2021 comparative and the later opening balances show the subsequent adjustments separately.

FY2021 finance costs change from RMB(91,057) to RMB(160,408) thousand, although the Note39 income adjustment list omits a finance-cost row. Note39 cash-flow interest expense changes from RMB90,931 to RMB160,283 thousand. No complete reconciliation beyond the printed note and primary statements is invented.

FY2022 Note39 prints original FY2021 cost of sales as (1.069,807), with a period in the first thousands separator. The actual original primary statement prints (1,069,807); published primary values follow the original statement and the malformed note string is retained as a source discrepancy.

Company FY2022 comparison is unexplained by Note38: equity RMB475,965 original versus RMB435,649 later, payables RMB43,067 versus RMB83,383, accumulated losses RMB(392,013) versus RMB(432,330), reserves RMB76,478 versus RMB76,479 thousand. Assets remain RMB778,473 thousand. The original statement is retained; no financial-guarantee or director-loan cause is inferred.

FY2022 Group cash RMB433,955 thousand is reclassified as cash/bank RMB414,955 plus fixed deposits RMB19,000 thousand. Comparative financing cash flow changes from RMB2,748 to RMB(16,252) thousand. This changes the cash-equivalent perimeter, not total assets or a newly inferred cash transaction.

FY2022 other investment RMB1,000 thousand moves from current in its original report to non-current in the FY2023 comparative. Non-current/current subtotals change by plus/minus RMB1,000 thousand and total assets remain unchanged. Deposits paid for non-current assets are nil in both reports.

FY2019 restatements and 1 January 2019 opening positions are separately retained under FY2020 Note2(f)(i). The original FY2019 income statement includes cessation-of-production and bond/derivative rows absent from the later presentation. Original rows and cash-flow decompositions remain available; the note does not provide a complete cash-flow bridge.

Source precision differences are preserved: FY2022 restated opening other payables RMB155,698 versus the FY2020 closing RMB155,697 thousand, and the corresponding opening liabilities differ by RMB1 thousand beyond the listed bond adjustment. No additional adjustment is invented.

Current Note5 subsidiary NCI carrying amount is RMB935/1,111 thousand, while consolidated NCI in the primary statement is RMB934/1,110 thousand for FY2023/FY2022. The RMB1 thousand differences are retained; consolidated primary totals are not changed to the note values.

The USD150,372,476 bondholder demand is translated as RMB963,775,184 in Note36 and RMB963,810,321 in the audit report/Note37. Both source conversions are retained; no invented exchange rate reconciles the RMB35,137 difference.

The RMB270 million settlement payable over 3.5 years is a proposed term sheet. The 2 April 2025 announcement and current annual Note37 say other terms/definitive agreements were still being finalised. This is not a completed settlement.

Annual shareholding snapshot is 12 December 2025, distinct from the 31 December 2023 financial position. Registered nominee accounts, direct holdings and overlapping deemed interests are retained separately; no nominee beneficial-owner map or additive total is inferred.

Top twenty registered accounts total 733,498,820 shares. The printed 63.79% equals the sum of rounded row percentages; dividing the exact share aggregate by 1,149,410,658 yields 63.82% rounded. Both printed and recomputed percentages are disclosed.

Four statutory directors are distinct from four senior managers. Wang Xiaowei is Director of Overseas Market, not a statutory director. Annual documents do not name a current CFO; the January/April 2026 meeting minutes refer to an unnamed CFO.

Dr Qiu Yang is the annual-report Company Secretary, but resigned effective 30 September 2026. The later official notice does not name a replacement. Huang Yupeng remains the named Chairman and CEO on that notice.

The FY2023 AGM held on 13 January 2026 re-elected Huang Yushan and Tan Qing Wen, Jeremy, and approved RT LLP for FY2024. It does not constitute a FY2024 annual report or remove the FY2023 Disclaimer of Opinion.

Note5 contains eighteen holding paths for fifteen distinct subsidiary entities. Grandness Anhui interests 16.7% and 83.3% total 100%; Grandness Sichuan paths 71.77% + 4.78% + 4.78% total 81.33% effective interest. Its subsidiary Sichuan Zhenying is immediately 100% held, not 100% effective Group-owned.

May Pipa was incorporated on 13 December 2023 under Garden Fresh (Shenzhen) Beverage Technology and wound up on 19 November 2024. It remains in the separately dated FY2023 subsidiary schedule; subsequent winding up is not backdated.

Garden Fresh Beverage Group proposed disposal received shareholder approval on 22 April 2026. The later transaction would remove a beverage group; shareholder approval is not proof of completion. FY2025 pro forma EPS and management results in the meeting appendix are unaudited and do not replace the FY2023 annual statements.

The April 2026 trading-resumption proposal is not approval to trade. The 20 August 2026 official update says SGX returned the application on 19 August because queries including audited prior-year accounts, AGMs and debts remained outstanding. No completed resumption is inferred.

Huang Yupeng

Chairman and Chief Executive Officer

Founder; combined Chairman/CEO confirmed by governance report and September 2026 signature.

Huang Yushan

Executive Director

Human resources and administration; her former CFO role is historical. Sister of Huang Yupeng as separately disclosed in 2026 EGM results. Re-elected at FY2023 AGM on 13 January 2026.

Li Xueying

Independent Director

Appointed 15 August 2022; Audit Committee Chairman according to directory; Nominating and Remuneration Committee member.

Tan Qing Wen, Jeremy

Independent Non-Executive Director

Biography heading TAN QINGWEN, JEREMY. Appointed 30 May 2023; Audit, Nominating and Remuneration Committee member. Re-elected 13 January 2026. Chairing the April 2026 EGM is a meeting role, not a new issuer Chairman appointment.

Zheng Yutang

Deputy Chief Production Officer

Senior management; joined Group in 2015; not a statutory Board director.

Yang Chuntao

Chief Marketing Officer

Senior management; not a statutory Board director.

Yang Jianhong

Chief Technical Officer

Senior management; not a statutory Board director.

Wang Xiaowei

Director of Overseas Market

Senior management; this functional Director title does not make her a statutory Board director.

Dr. Qiu Yang

Company Secretary (annual-report snapshot; subsequently resigned)

Subsequent resignation effective 30 September 2026 is separately retained; no replacement is named in that announcement.

Company Secretary resignation

Dr Qiu Yang resigned with effect from 30 September 2026

Later official notice; annual directory remains a historical snapshot. No replacement disclosed. As reported at 2026-09-30

FY2023 AGM outcomes

Huang Yushan and Tan Qing Wen, Jeremy re-elected; RT LLP re-appointed for FY2024

Meeting held 13 January 2026; historical FY2023 accounts adopted. RT LLP appointment does not supply a FY2024 annual report. As reported at 2026-01-13

Roles listed in Annual Report 2023; current appointments are not independently verified.

Holdings

Ownership

Twenty registered accounts, five substantial-shareholder positions and six context facts. Annual ownership register is dated 12 December 2025, not the FY2023 balance-sheet date. Direct, deemed and registered blocks must not be summed together. Dashes retained as printed. Source aggregate 63.79% sums rounded row percentages; exact aggregate is 63.82%.

FY2023 audit is a Disclaimer of Opinion, signed by RT LLP on 7 November 2025. Going-concern uncertainty, bond litigation exposure and unrecognised Company financial-guarantee provisions form the basis. Management statements about a true and fair view do not constitute the auditor opinion.

Reporting year is FY2023 ended 31 December 2023; signature and authorisation in November 2025 and SGX release on 28 December 2025 do not create a FY2025 annual report. Later FY2025 management accounts and disposal pro forma calculations are unaudited and are not substituted for annual statements.

FY2021 restatement changes owner result from RMB(36,006) to RMB145,465 thousand, and opening retained profits from RMB821,437 to RMB342,379 thousand. Source FY2022 Note39 discloses the adjustments. Original FY2021 statements and separately dated 1 January 2021 opening positions are retained.

The restated 1 January 2021 opening positions are not relabelled as FY2020 closing statements. No fully restated FY2020 profit or cash-flow series is disclosed in Note39. FY2020 closing statements remain from the FY2021 comparative and the later opening balances show the subsequent adjustments separately.

FY2021 finance costs change from RMB(91,057) to RMB(160,408) thousand, although the Note39 income adjustment list omits a finance-cost row. Note39 cash-flow interest expense changes from RMB90,931 to RMB160,283 thousand. No complete reconciliation beyond the printed note and primary statements is invented.

FY2022 Note39 prints original FY2021 cost of sales as (1.069,807), with a period in the first thousands separator. The actual original primary statement prints (1,069,807); published primary values follow the original statement and the malformed note string is retained as a source discrepancy.

Company FY2022 comparison is unexplained by Note38: equity RMB475,965 original versus RMB435,649 later, payables RMB43,067 versus RMB83,383, accumulated losses RMB(392,013) versus RMB(432,330), reserves RMB76,478 versus RMB76,479 thousand. Assets remain RMB778,473 thousand. The original statement is retained; no financial-guarantee or director-loan cause is inferred.

FY2022 Group cash RMB433,955 thousand is reclassified as cash/bank RMB414,955 plus fixed deposits RMB19,000 thousand. Comparative financing cash flow changes from RMB2,748 to RMB(16,252) thousand. This changes the cash-equivalent perimeter, not total assets or a newly inferred cash transaction.

FY2022 other investment RMB1,000 thousand moves from current in its original report to non-current in the FY2023 comparative. Non-current/current subtotals change by plus/minus RMB1,000 thousand and total assets remain unchanged. Deposits paid for non-current assets are nil in both reports.

FY2019 restatements and 1 January 2019 opening positions are separately retained under FY2020 Note2(f)(i). The original FY2019 income statement includes cessation-of-production and bond/derivative rows absent from the later presentation. Original rows and cash-flow decompositions remain available; the note does not provide a complete cash-flow bridge.

Source precision differences are preserved: FY2022 restated opening other payables RMB155,698 versus the FY2020 closing RMB155,697 thousand, and the corresponding opening liabilities differ by RMB1 thousand beyond the listed bond adjustment. No additional adjustment is invented.

Current Note5 subsidiary NCI carrying amount is RMB935/1,111 thousand, while consolidated NCI in the primary statement is RMB934/1,110 thousand for FY2023/FY2022. The RMB1 thousand differences are retained; consolidated primary totals are not changed to the note values.

The USD150,372,476 bondholder demand is translated as RMB963,775,184 in Note36 and RMB963,810,321 in the audit report/Note37. Both source conversions are retained; no invented exchange rate reconciles the RMB35,137 difference.

The RMB270 million settlement payable over 3.5 years is a proposed term sheet. The 2 April 2025 announcement and current annual Note37 say other terms/definitive agreements were still being finalised. This is not a completed settlement.

Annual shareholding snapshot is 12 December 2025, distinct from the 31 December 2023 financial position. Registered nominee accounts, direct holdings and overlapping deemed interests are retained separately; no nominee beneficial-owner map or additive total is inferred.

Top twenty registered accounts total 733,498,820 shares. The printed 63.79% equals the sum of rounded row percentages; dividing the exact share aggregate by 1,149,410,658 yields 63.82% rounded. Both printed and recomputed percentages are disclosed.

Four statutory directors are distinct from four senior managers. Wang Xiaowei is Director of Overseas Market, not a statutory director. Annual documents do not name a current CFO; the January/April 2026 meeting minutes refer to an unnamed CFO.

Dr Qiu Yang is the annual-report Company Secretary, but resigned effective 30 September 2026. The later official notice does not name a replacement. Huang Yupeng remains the named Chairman and CEO on that notice.

The FY2023 AGM held on 13 January 2026 re-elected Huang Yushan and Tan Qing Wen, Jeremy, and approved RT LLP for FY2024. It does not constitute a FY2024 annual report or remove the FY2023 Disclaimer of Opinion.

Note5 contains eighteen holding paths for fifteen distinct subsidiary entities. Grandness Anhui interests 16.7% and 83.3% total 100%; Grandness Sichuan paths 71.77% + 4.78% + 4.78% total 81.33% effective interest. Its subsidiary Sichuan Zhenying is immediately 100% held, not 100% effective Group-owned.

May Pipa was incorporated on 13 December 2023 under Garden Fresh (Shenzhen) Beverage Technology and wound up on 19 November 2024. It remains in the separately dated FY2023 subsidiary schedule; subsequent winding up is not backdated.

Garden Fresh Beverage Group proposed disposal received shareholder approval on 22 April 2026. The later transaction would remove a beverage group; shareholder approval is not proof of completion. FY2025 pro forma EPS and management results in the meeting appendix are unaudited and do not replace the FY2023 annual statements.

The April 2026 trading-resumption proposal is not approval to trade. The 20 August 2026 official update says SGX returned the application on 19 August because queries including audited prior-year accounts, AGMs and debts remained outstanding. No completed resumption is inferred.

Huang Yupeng

Direct 352,124,087 shares; 30.64%; deemed – shares; –%

Substantial shareholder register at 12 December 2025. Direct and deemed blocks overlap; do not add related parties or nominee accounts. As reported at 2025-12-12

Chalermchai Mahagitsiri

11.35%Total interest

Direct – shares–%deemed 130,488,508 shares
Substantial shareholder register at 12 December 2025. Direct and deemed blocks overlap; do not add related parties or nominee accounts. Deemed interest through Soleado Holdings Pte. Ltd. and PM Group Company Limited. As reported at 2025-12-12

Soleado Holdings Pte. Ltd.

Direct 93,544,559 shares; 8.14%; deemed – shares; –%

Substantial shareholder register at 12 December 2025. Direct and deemed blocks overlap; do not add related parties or nominee accounts. As reported at 2025-12-12

Thoresen Thai Agencies Public Company Limited

8.14%Total interest

Direct – shares–%deemed 93,544,559 shares
Substantial shareholder register at 12 December 2025. Direct and deemed blocks overlap; do not add related parties or nominee accounts. Deemed interest through Soleado Holdings Pte. Ltd.; same 93,544,559-share block. As reported at 2025-12-12

JW Capital Group Limited

Direct 170,000,000 shares; 14.79%; deemed – shares; –%

Substantial shareholder register at 12 December 2025. Direct and deemed blocks overlap; do not add related parties or nominee accounts. As reported at 2025-12-12

Issued ordinary shares

1,149,410,658 whole shares

Annual register at 12 December 2025. As reported at 2025-12-12

Registered shareholders

2,383 holders

Five distribution bands; holder count is distinct from share count. As reported at 2025-12-12

Twenty largest registered accounts

63.79%Total interest

733,498,820 shares
Printed 63.79% is the sum of rounded row percentages; exact 733,498,820 / 1,149,410,658 recomputes to 63.82%. Both are retained. As reported at 2025-12-12

Public float

approximately 43.22%

Issuer statement under Rule 723 at 12 December 2025. As reported at 2025-12-12

Registered and beneficial positions

Huang Yupeng registered 102,100,000 versus substantial direct 352,124,087; Soleado registered 81,450,857 versus substantial direct 93,544,559 shares

Registered and beneficial registers are distinct views at the same date. No nominee-to-beneficial mapping is inferred. As reported at 2025-12-12

FY2023 director interest

Huang Yupeng 350,024,087 shares at both 1 January and 31 December 2023

Historical director register is distinct from December 2025 substantial holdings; no share transaction is inferred from the difference. As reported at 2023-12-31

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2025-12-12 · PDF p. 119

Registered holderInterestShares / unitsSource
RAFFLES NOMINEES (PTE) LIMITED165,081,159 shares; 14.36%PDF p. 1192025-12-12
HUANG YUPENG102,100,000 shares; 8.88%PDF p. 1192025-12-12
SOLEADO HOLDINGS PTE LTD81,450,857 shares; 7.09%PDF p. 1192025-12-12
CITIBANK NOMINEES SINGAPORE PTE LTD80,444,580 shares; 7.00%PDF p. 1192025-12-12
DBS NOMINEES PTE LTD61,393,703 shares; 5.34%PDF p. 1192025-12-12
SOO WEE KIAT (SU WEIJIE)42,683,900 shares; 3.71%PDF p. 1192025-12-12
BNP PARIBAS NOMINEES SINGAPORE PTE LTD27,978,008 shares; 2.43%PDF p. 1192025-12-12
UOB KAY HIAN PTE LTD24,949,071 shares; 2.17%PDF p. 1192025-12-12
OCBC SECURITIES PRIVATE LTD21,289,970 shares; 1.85%PDF p. 1192025-12-12
DBSN SERVICES PTE LTD20,000,000 shares; 1.74%PDF p. 1192025-12-12
PHILLIP SECURITIES PTE LTD16,308,334 shares; 1.42%PDF p. 1192025-12-12
OCBC NOMINEES SINGAPORE PTE LTD14,607,761 shares; 1.27%PDF p. 1192025-12-12
CHEN TIK LUNG @ CHAN TIK LUNG14,500,000 shares; 1.26%PDF p. 1192025-12-12
UNITED OVERSEAS BANK NOMINEES PTE LTD13,617,470 shares; 1.18%PDF p. 1192025-12-12
HSBC (SINGAPORE) NOMINEES PTE LTD9,941,407 shares; 0.86%PDF p. 1192025-12-12
ZHU XILIN8,822,500 shares; 0.77%PDF p. 1192025-12-12
NG KHENG IMM MRS LEE SWEE KHIANG8,188,000 shares; 0.71%PDF p. 1192025-12-12
TAN CHONG MENG7,165,400 shares; 0.62%PDF p. 1192025-12-12
HUANG SHU HUA6,976,700 shares; 0.61%PDF p. 1192025-12-12
SEAH KOK BENG6,000,000 shares; 0.52%PDF p. 1192025-12-12

Group structure

Main operating subsidiaries

Fifteen distinct subsidiary legal entities disclosed through eighteen holding-path rows in Note 5. Grandness Anhui appears twice and Grandness Sichuan three times; no duplicate entities are invented. Immediate-path percentages and effective Group interests are distinguished. May Pipa and Sichuan Zhenying were new in 2023. Later proposed Garden Fresh Beverage disposal and approval are separate from the FY2023 structure; no completed sale is inferred.

FY2023 audit is a Disclaimer of Opinion, signed by RT LLP on 7 November 2025. Going-concern uncertainty, bond litigation exposure and unrecognised Company financial-guarantee provisions form the basis. Management statements about a true and fair view do not constitute the auditor opinion.

Reporting year is FY2023 ended 31 December 2023; signature and authorisation in November 2025 and SGX release on 28 December 2025 do not create a FY2025 annual report. Later FY2025 management accounts and disposal pro forma calculations are unaudited and are not substituted for annual statements.

FY2021 restatement changes owner result from RMB(36,006) to RMB145,465 thousand, and opening retained profits from RMB821,437 to RMB342,379 thousand. Source FY2022 Note39 discloses the adjustments. Original FY2021 statements and separately dated 1 January 2021 opening positions are retained.

The restated 1 January 2021 opening positions are not relabelled as FY2020 closing statements. No fully restated FY2020 profit or cash-flow series is disclosed in Note39. FY2020 closing statements remain from the FY2021 comparative and the later opening balances show the subsequent adjustments separately.

FY2021 finance costs change from RMB(91,057) to RMB(160,408) thousand, although the Note39 income adjustment list omits a finance-cost row. Note39 cash-flow interest expense changes from RMB90,931 to RMB160,283 thousand. No complete reconciliation beyond the printed note and primary statements is invented.

FY2022 Note39 prints original FY2021 cost of sales as (1.069,807), with a period in the first thousands separator. The actual original primary statement prints (1,069,807); published primary values follow the original statement and the malformed note string is retained as a source discrepancy.

Company FY2022 comparison is unexplained by Note38: equity RMB475,965 original versus RMB435,649 later, payables RMB43,067 versus RMB83,383, accumulated losses RMB(392,013) versus RMB(432,330), reserves RMB76,478 versus RMB76,479 thousand. Assets remain RMB778,473 thousand. The original statement is retained; no financial-guarantee or director-loan cause is inferred.

FY2022 Group cash RMB433,955 thousand is reclassified as cash/bank RMB414,955 plus fixed deposits RMB19,000 thousand. Comparative financing cash flow changes from RMB2,748 to RMB(16,252) thousand. This changes the cash-equivalent perimeter, not total assets or a newly inferred cash transaction.

FY2022 other investment RMB1,000 thousand moves from current in its original report to non-current in the FY2023 comparative. Non-current/current subtotals change by plus/minus RMB1,000 thousand and total assets remain unchanged. Deposits paid for non-current assets are nil in both reports.

FY2019 restatements and 1 January 2019 opening positions are separately retained under FY2020 Note2(f)(i). The original FY2019 income statement includes cessation-of-production and bond/derivative rows absent from the later presentation. Original rows and cash-flow decompositions remain available; the note does not provide a complete cash-flow bridge.

Source precision differences are preserved: FY2022 restated opening other payables RMB155,698 versus the FY2020 closing RMB155,697 thousand, and the corresponding opening liabilities differ by RMB1 thousand beyond the listed bond adjustment. No additional adjustment is invented.

Current Note5 subsidiary NCI carrying amount is RMB935/1,111 thousand, while consolidated NCI in the primary statement is RMB934/1,110 thousand for FY2023/FY2022. The RMB1 thousand differences are retained; consolidated primary totals are not changed to the note values.

The USD150,372,476 bondholder demand is translated as RMB963,775,184 in Note36 and RMB963,810,321 in the audit report/Note37. Both source conversions are retained; no invented exchange rate reconciles the RMB35,137 difference.

The RMB270 million settlement payable over 3.5 years is a proposed term sheet. The 2 April 2025 announcement and current annual Note37 say other terms/definitive agreements were still being finalised. This is not a completed settlement.

Annual shareholding snapshot is 12 December 2025, distinct from the 31 December 2023 financial position. Registered nominee accounts, direct holdings and overlapping deemed interests are retained separately; no nominee beneficial-owner map or additive total is inferred.

Top twenty registered accounts total 733,498,820 shares. The printed 63.79% equals the sum of rounded row percentages; dividing the exact share aggregate by 1,149,410,658 yields 63.82% rounded. Both printed and recomputed percentages are disclosed.

Four statutory directors are distinct from four senior managers. Wang Xiaowei is Director of Overseas Market, not a statutory director. Annual documents do not name a current CFO; the January/April 2026 meeting minutes refer to an unnamed CFO.

Dr Qiu Yang is the annual-report Company Secretary, but resigned effective 30 September 2026. The later official notice does not name a replacement. Huang Yupeng remains the named Chairman and CEO on that notice.

The FY2023 AGM held on 13 January 2026 re-elected Huang Yushan and Tan Qing Wen, Jeremy, and approved RT LLP for FY2024. It does not constitute a FY2024 annual report or remove the FY2023 Disclaimer of Opinion.

Note5 contains eighteen holding paths for fifteen distinct subsidiary entities. Grandness Anhui interests 16.7% and 83.3% total 100%; Grandness Sichuan paths 71.77% + 4.78% + 4.78% total 81.33% effective interest. Its subsidiary Sichuan Zhenying is immediately 100% held, not 100% effective Group-owned.

May Pipa was incorporated on 13 December 2023 under Garden Fresh (Shenzhen) Beverage Technology and wound up on 19 November 2024. It remains in the separately dated FY2023 subsidiary schedule; subsequent winding up is not backdated.

Garden Fresh Beverage Group proposed disposal received shareholder approval on 22 April 2026. The later transaction would remove a beverage group; shareholder approval is not proof of completion. FY2025 pro forma EPS and management results in the meeting appendix are unaudited and do not replace the FY2023 annual statements.

The April 2026 trading-resumption proposal is not approval to trade. The 20 August 2026 official update says SGX returned the application on 19 August because queries including audited prior-year accounts, AGMs and debts remained outstanding. No completed resumption is inferred.

CompanyMarketOwnership interest
Grandness (HK) Industry Co., Ltd.Held by Company; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 Hong Kong; interest/voting rights 2023/2022 100/100%; Investment holding
Shenzhen Grandness Industry Group Co., Ltd.Held by Grandness (HK) Industry Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Sale of canned vegetables and canned fruits
Grandness (Anhui) Foods Co., Ltd.Held by Grandness (HK) Industry Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. Two wholly-owned Group parents hold 16.7% and 83.3%; aggregate effective Group interest is 100% (Note 5 footnote @).PDF p. 722023-12-31 PRC; interest/voting rights 2023/2022 16.7@/16.7@%; Production and sale of fruits and vegetable juices
Garden Fresh Group Holding Co., Ltd.Held by Grandness (HK) Industry Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 Cayman Islands; interest/voting rights 2023/2022 100/100%; Investment holding
Garden Fresh Beverage Group Co., Ltd.Held by Garden Fresh Group Holding Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 British Virgin Islands; interest/voting rights 2023/2022 100/100%; Investment holding
Garden Fresh (HK) Fruit & Vegetable Beverage Co., Ltd.Held by Garden Fresh Beverage Group Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 Hong Kong; interest/voting rights 2023/2022 100/100%; Investment holding
Garden Fresh (Shenzhen) Fruit & Vegetable Beverage Co., Ltd.Held by Garden Fresh (HK) Fruit & Vegetable Beverage Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Sale of fruits and vegetable juices
Garden Fresh (Shenzhen) Beverage Technology Co., Ltd.Held by Garden Fresh (Shenzhen) Fruit & Vegetable Beverage Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 722023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Investment holding
Garden Fresh (Anhui) Fruit & Vegetable Beverage Co., Ltd.Held by Garden Fresh (Shenzhen) Beverage Technology Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Production and sale of fruits and vegetable juices
Garden Fresh (Hubei) Food & Beverage Co., Ltd.Held by Garden Fresh (Shenzhen) Beverage Technology Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Production and sale of fruits and vegetable juices
Garden Fresh (Sichuan) Fruit & Vegetable Beverage Co., Ltd.Held by Garden Fresh (Shenzhen) Beverage Technology Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Production and sale of fruits and vegetable juices
May Pipa (Chengdu) Foods Co., Ltd.Held by Garden Fresh (Shenzhen) Beverage Technology Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. FY2022 subsequent-events note confirms the same Beverage Technology parent, incorporation on 13 December 2023 and winding up on 19 November 2024. The winding up is subsequent to the FY2023 balance-sheet date.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/–%; Inactive
Grandness (Sichuan) Foods Co., Ltd.Held by Shenzhen Grandness Industry Group Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. Three current paths 71.77% + 4.78% + 4.78% = 81.33% effective Group interest; prior paths 76.55% + 4.78% = 81.33%. These are repeated legal-entity paths, not three different subsidiaries.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 71.77#/76.55#%; Inactive
Grandness (Hubei) Foods Co., Ltd.Held by Shenzhen Grandness Industry Group Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/100%; Production and sale of canned vegetables and canned fruits
Grandness (Anhui) Foods Co., Ltd.Held by Shenzhen Grandness Industry Group Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. Two wholly-owned Group parents hold 16.7% and 83.3%; aggregate effective Group interest is 100% (Note 5 footnote @).PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 83.3@/83.3@%; Production and sale of canned vegetables and canned fruits
Grandness (Sichuan) Foods Co., Ltd.Held by Grandness (Hubei) Foods Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. Three current paths 71.77% + 4.78% + 4.78% = 81.33% effective Group interest; prior paths 76.55% + 4.78% = 81.33%. These are repeated legal-entity paths, not three different subsidiaries.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 4.78#/4.78#%; Inactive
Grandness (Sichuan) Foods Co., Ltd.Held by Grandness (Anhui) Foods Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. Three current paths 71.77% + 4.78% + 4.78% = 81.33% effective Group interest; prior paths 76.55% + 4.78% = 81.33%. These are repeated legal-entity paths, not three different subsidiaries.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 4.78#/–%; Inactive
Sichuan Zhenying Property Management Co., Ltd.Held by Grandness (Sichuan) Foods Co., Ltd.; 2023/2022 percentages describe this disclosed holding path. Source footnote markers retained. 100% is the immediate holding through an 81.33%-effective Group parent; it is not a separate 100% effective Group interest.PDF p. 732023-12-31 PRC; interest/voting rights 2023/2022 100/–%; Property management
May Pipa subsequent winding upFY2022 subsequent-events note records incorporation on 13 December 2023 by Garden Fresh (Shenzhen) Beverage Technology Co., Ltd., consistent with FY2023 Note 5. FY2023 membership remains separately dated.PDF p. 1112024-11-19 Wound up on 19 November 2024
Garden Fresh Beverage Group disposalLater proposed major and interested-person transaction; shareholder approval is not evidence of legal completion. FY2023 group structure remains separately dated.PDF p. 22026-04-22 Proposed sale of the entire issued share capital to Ideutsch Health Technology Group (HK) Co., Ltd.; shareholder approval obtained on 22 April 2026

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
ZHENG YUTANG Deputy Chief Production Officer PDF p. 12
YANG JIANHONG Chief Technical Officer PDF p. 12
YANG CHUNTAO Chief Marketing Officer PDF p. 12
WANG XIAOWEI Director of Overseas Market PDF p. 12

Extracted from Annual Report 2023 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
TOTAL 1,149,410,658 shares Total issued shares as at 12 December 2025 · As at 2025-12-12 PDF p. 119

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 2,383 shareholders Total shareholders as at 12 December 2025 · As at 2025-12-12 PDF p. 119
1 – 99 37 holders; 1.55%; 1,792 shares; 0.00% Size of shareholdings, 12 December 2025 · As at 2025-12-12 PDF p. 119
100 – 1,000 60 holders; 2.52%; 30,543 shares; 0.00% Size of shareholdings, 12 December 2025 · As at 2025-12-12 PDF p. 119
1,001 – 10,000 443 holders; 18.59%; 2,946,584 shares; 0.26% Size of shareholdings, 12 December 2025 · As at 2025-12-12 PDF p. 119
10,001 – 1,000,000 1,744 holders; 73.19%; 231,369,897 shares; 20.13% Size of shareholdings, 12 December 2025 · As at 2025-12-12 PDF p. 119
1,000,001 and above 99 holders; 4.15%; 915,061,842 shares; 79.61% Size of shareholdings, 12 December 2025 · As at 2025-12-12 PDF p. 119

Free float

ItemValuePeriod / scopeSource
PERCENTAGE OF SHAREHOLDINGS IN PUBLIC’S HANDS approximately 43.22% Shares held in public's hands as at 12 December 2025 · As at 2025-12-12 PDF p. 120
PERCENTAGE OF SHAREHOLDINGS IN PUBLIC’S HANDS the Company has complied with Rule 723 of the Listing Manual of the SGX-ST. As at 12 December 2025 · As at 2025-12-12 PDF p. 120

Extracted from Annual Report 2023 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Soleado Holdings Pte. Ltd. RMB22,492,000 Interested person transactions under SGX Rule 907, FY2023; Group; Soleado Holdings Pte. Ltd. (substantial shareholder) PDF p. 29
Interest charged on loan from a related party (Note 20 and 24(d)) 22,492 RMB'000 Group, FY2023 (comparative 2022: 20,272) PDF p. 100

Contingent liabilities

ItemValuePeriod / scopeSource
Contingencies approximately RMB126,746 as at 31 December 2023 (2022: RMB116,181) Group, as at 31 December 2023 · As at 2023-12-31 PDF p. 117
Goldman Sachs Investments Holdings (Asia) Limited claiming RMB396,577,356 and USD150,372,476 (equivalent to RMB963,775,184) Company/Group; claim owed by subsidiary Garden Fresh (HK) Fruit & Vegetable Beverage Co., Limited · As at 2023-12-31 PDF p. 117
Soleado Holdings Pte. Ltd. RMB236.5 million Group and Company; loan principal and interest due to related party · As at 2023-12-31 PDF p. 117

Director remuneration

ItemValuePeriod / scopeSource
S$250,000 to below S$1,500,000 1 number of directors Executive Directors, number of directors, 2023 (2022: 1) PDF p. 21
Huang Yupeng 709 S$'000 Director (Chairman and CEO), FY2023 total remuneration PDF p. 21
Li Xueying 20 S$'000 Director, FY2023 total remuneration (fees) PDF p. 21
Tan Qing Wen, Jeremy 20 S$'000 Director, FY2023 total remuneration (fees) PDF p. 21

Subsequent events

ItemValuePeriod / scopeSource
Bank borrowings obtained and repaid obtained additional bank loans totalling RMB135.5 million and repaid bank loans totalling RMB134.0 million Group, after the reporting period PDF p. 118
Receipt of letter of demand from bondholders and proposed debt settlement the settlement amount is RMB270 million, payable over a period of 3.5 years Company/Group; proposed final settlement of amounts under the relevant bonds PDF p. 118

Outlook

ItemValuePeriod / scopeSource
Chairman's Statement – outlook Looking forward, the Group remains focused on strengthening execution, optimising cost structures, and Group, Chairman and CEO statement PDF p. 7

Extracted from Annual Report 2023 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2023 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
20 Jul 2007
Telephone
65 6812 1611
Fax
65 6812 1601
Registered Office
8 Marina View #11-11
Asia Square Tower 1
Singapore 018960
Secretary
Dr Qiu Yang
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
RT LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE LTD.
Country
SINGAPORE
Security Type
stocks